IRWD — IRONWOOD PHARMACEUTICALS INC
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1446847 ·
Last close
$3.82
Market Cap
$631.22M
52W High
$5.78
52W Low
$1.41
ADV30
2,036,397
Next earnings
2026-11-09
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 113,041,000 | — | 79,307,000 | 51,291,000 | 285,128,000 | 79,127,000 | 446,971,000 |
| Mar 2026 | 106,506,000 | — | 72,533,000 | 40,773,000 | 434,566,000 | 220,471,000 | 651,710,000 |
| Dec 2025 | 47,709,000 | — | 6,553,000 | -2,276,000 | 396,901,000 | 215,456,000 | 658,736,000 |
| Sep 2025 | 122,060,000 | — | 77,684,000 | 40,080,000 | 396,062,000 | 140,407,000 | 660,219,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$112,211,000
Investing CF
$-3,000
Financing CF
$210,000
CapEx
$-35,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.60
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,581,654,000
Inventory
—
Receivables
$112,732,000
ST Investments
—
EBIT TTM
$239,867,000
Pretax Income TTM
$207,378,000
Interest Exp TTM
$32,489,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$389,316,000
EBITDA
$238,104,992
Free Cash Flow
$121,834,752
Enterprise Value
$991,917,952
Total Cash
$79,127,000
Total Debt
$396,865,984
Shares Out
165,239,947
Trailing EPS
$0.79
Book Value
$-0.98
ROE
—
ROA
47.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 296,151,000 | 118,759,000 | 24,017,000 | 396,901,000 | 658,736,000 | -261,835,000 | 127,044,000 |
| Dec 2024 | 351,410,000 | 95,717,000 | 880,000 | 350,908,000 | 652,243,000 | -301,335,000 | 103,549,000 |
| Dec 2023 | 442,735,000 | 168,336,000 | -1,002,239,000 | 471,073,000 | 817,368,000 | -346,295,000 | 183,427,000 |
| Dec 2022 | 410,596,000 | 250,337,000 | 175,065,000 | 1,100,519,000 | 448,141,000 | 652,378,000 | 273,763,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$361,514,000
NetIncome TTM
$102,176,000
OpCashFlow TTM
—
Assets (Latest)
$434,566,000
Forward EPS
$1.50
Max Pain — expiry 2026-11-20
max pain strike: $2.50 · spot: $3.82 · call oi: 3,939 · put oi: 2,344
Expected Move to 2026-11-20:
±$1.40
(36.65%) —
implied range
$2.42 –
$5.22
· ATM straddle on $5.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CLYM | Climb Bio, Inc. | $631.80M | $11.00 | — |
| SLN | Silence Therapeutics plc | $612.84M | $9.86 | — |
| AQST | Aquestive Therapeutics, Inc. | $599.95M | $4.78 | — |
| STTK | Shattuck Labs, Inc. | $599.17M | $5.97 | — |
| FTH | Faeth Therapeutics, Inc. | $672.63M | $26.03 | — |
News headlines (Yahoo Finance, 1h cache)
Ironwood Pharmaceuticals to Participate in the Wells Fargo 21st Annual Healthcare Conference
2026-09-03 20:05 · Yahoo
Ironwood (IRWD) Q2 2026 Earnings Call Transcript
2026-08-13 17:43 · Yahoo
Ironwood Pharmaceuticals (IRWD) Is Up 14.2% After Raising 2026 Revenue Guidance – Has The Bull Case Changed?
2026-08-07 04:31 · Yahoo
Ironwood Pharmaceuticals to Host Second Quarter 2026 Investor Update Call
2026-07-30 20:05 · Yahoo
Ironwood Pharmaceuticals (IRWD) Gains From Strong Fiscal Q1 2026 Earnings Momentum
2026-07-03 13:12 · Yahoo
Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker
2026-06-26 08:59 · Yahoo
Will Linzess Continue to Aid Ironwood's Top-Line Growth in Q3?
2026-10-07 13:57 · Yahoo
Ironwood Appoints Dr. Jeffrey Silber Chief Medical Officer and Head of Research and Drug Development; STARS-2 Trial Initiated in June and Is Now Actively Recruiting Patients
2026-07-14 11:30 · Yahoo
PGEN vs. IRWD: Which Biotech Stock Offers Better Growth Potential?
2026-09-30 15:08 · Yahoo
5 Small Drug Stocks Poised to Benefit From a Biotech Recovery
2026-09-14 13:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.